257 related articles for article (PubMed ID: 12683938)
21. Termination of growth hormone pulse-induced STAT5b signaling.
Gebert CA; Park SH; Waxman DJ
Mol Endocrinol; 1999 Jan; 13(1):38-56. PubMed ID: 9892011
[TBL] [Abstract][Full Text] [Related]
22. Growth hormone-regulated intracellular signaling in UMR 106 osteosarcoma cells.
Morales O; Lindgren U; Haldosén LA
J Bone Miner Res; 2000 Nov; 15(11):2284-90. PubMed ID: 11092411
[TBL] [Abstract][Full Text] [Related]
23. Growth hormone-dependent differentiation of 3T3-F442A preadipocytes requires Janus kinase/signal transducer and activator of transcription but not mitogen-activated protein kinase or p70 S6 kinase signaling.
Yarwood SJ; Sale EM; Sale GJ; Houslay MD; Kilgour E; Anderson NG
J Biol Chem; 1999 Mar; 274(13):8662-8. PubMed ID: 10085104
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the inhibitory effect of growth hormone on primary preadipocyte differentiation.
Hansen LH; Madsen B; Teisner B; Nielsen JH; Billestrup N
Mol Endocrinol; 1998 Aug; 12(8):1140-9. PubMed ID: 9717840
[TBL] [Abstract][Full Text] [Related]
25. Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation.
Wang X; Darus CJ; Xu BC; Kopchick JJ
Mol Endocrinol; 1996 Oct; 10(10):1249-60. PubMed ID: 9121492
[TBL] [Abstract][Full Text] [Related]
26. Activation of the Jak/Stat signal transduction pathway in GH-treated rat osteoblast-like cells in culture.
Gerland K; Bataillé-Simoneau N; Baslé M; Fourcin M; Gascan H; Mercier L
Mol Cell Endocrinol; 2000 Oct; 168(1-2):1-9. PubMed ID: 11064147
[TBL] [Abstract][Full Text] [Related]
27. Mitogen-activated protein kinase kinase inhibition decreases growth hormone stimulated transcription mediated by STAT5.
Pircher TJ; Flores-Morales A; Mui AL; Saltiel AR; Norstedt G; Gustafsson JA; Haldosén LA
Mol Cell Endocrinol; 1997 Oct; 133(2):169-76. PubMed ID: 9406863
[TBL] [Abstract][Full Text] [Related]
28. Lactogenic hormone-inducible phosphorylation and gamma-activated site-binding activities of Stat5b in primary rat Leydig cells and MA-10 mouse Leydig tumor cells.
Kanzaki M; Morris PL
Endocrinology; 1998 Apr; 139(4):1872-82. PubMed ID: 9528973
[TBL] [Abstract][Full Text] [Related]
29. 1Alpha,25-dihydroxyvitamin D3 inhibits GH-induced expression of SOCS-3 and CIS and prolongs growth hormone signaling via the Janus kinase (JAK2)/signal transducers and activators of transcription (STAT5) system in osteoblast-like cells.
Morales O; Faulds MH; Lindgren UJ; Haldosén LA
J Biol Chem; 2002 Sep; 277(38):34879-84. PubMed ID: 12107179
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors.
Groner B; Fritsche M; Stöcklin E; Berchtold S; Merkle C; Moriggl R; Pfitzner E
Growth Horm IGF Res; 2000 Apr; 10 Suppl B():S15-20. PubMed ID: 10984248
[TBL] [Abstract][Full Text] [Related]
31. Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans.
Brelje TC; Stout LE; Bhagroo NV; Sorenson RL
Endocrinology; 2004 Sep; 145(9):4162-75. PubMed ID: 15142985
[TBL] [Abstract][Full Text] [Related]
32. Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone.
Silva CM; Lu H; Day RN
Mol Endocrinol; 1996 May; 10(5):508-18. PubMed ID: 8732682
[TBL] [Abstract][Full Text] [Related]
33. Involvement of STAT5 (signal transducer and activator of transcription 5) and HNF-4 (hepatocyte nuclear factor 4) in the transcriptional control of the hnf6 gene by growth hormone.
Lahuna O; Rastegar M; Maiter D; Thissen JP; Lemaigre FP; Rousseau GG
Mol Endocrinol; 2000 Feb; 14(2):285-94. PubMed ID: 10674400
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
35. Constitutively active signal transducer and activator of transcription 5 can replace the requirement for growth hormone in adipogenesis of 3T3-F442A preadipocytes.
Shang CA; Waters MJ
Mol Endocrinol; 2003 Dec; 17(12):2494-508. PubMed ID: 12970402
[TBL] [Abstract][Full Text] [Related]
36. c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription.
Goh EL; Zhu T; Leong WY; Lobie PE
Endocrinology; 2002 Sep; 143(9):3590-603. PubMed ID: 12193575
[TBL] [Abstract][Full Text] [Related]
37. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.
Paukku K; Valgeirsdóttir S; Saharinen P; Bergman M; Heldin CH; Silvennoinen O
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):759-66. PubMed ID: 10642538
[TBL] [Abstract][Full Text] [Related]
38. Suppression of growth hormone (GH) Janus tyrosine kinase 2/signal transducer and activator of transcription 5 signaling pathway in transgenic mice overexpressing bovine GH.
Miquet JG; Sotelo AI; Bartke A; Turyn D
Endocrinology; 2004 Jun; 145(6):2824-32. PubMed ID: 15016718
[TBL] [Abstract][Full Text] [Related]
39. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of endogenous GH and interleukin-6 receptors selectively activates different Jaks and Stats, with a Stat5 specific synergistic effect of dexamethasone.
von Laue S; Finidori J; Maamra M; Shen XY; Justice S; Dobson PR; Ross RJ
J Endocrinol; 2000 May; 165(2):301-11. PubMed ID: 10810294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
